Your pet may increase your glaucoma risk

Article

A recent study published in the American Journal of Ophthalmology, found that exposure to cats and cockroaches may increase the risk for glaucoma, while contact with dogs could help guard against the disease.

Los Angeles-A recent study published in the American Journal of Ophthalmology, found that exposure to cats and cockroaches may increase the risk for glaucoma, while contact with dogs could help guard against the disease.

Researchers from the University of California, Los Angeles, analyzed data from 1,678 participants from the National Health and Nutritional Examination Survey (NHANES). The participants underwent allergy testing for cats, dogs, cockroaches, rodents, and dust mites. Researchers also noted any use of steroids.

Related: Rise in erectile dysfunction associated with glaucoma

The study found that people with glaucoma-who consisted of 5.1 percent of the study’s participants-had significantly higher levels of the allergic antibody immunoglobulin E (IgE) to cats and cockroaches (although elevated IgE levels do not mean a person has an allergy).

Of the participants who were diagnosed with glaucoma, 14.3 percent had significantly elevated IgE levels to cats and 19.1 percent to cockroaches. In comparison, 10 percent of the participants without glaucoma had elevated IgE levels to either cats or cockroaches.

Next: A win for dog people 

 

A win for dog people

The study also found that the levels of IgE to dog allergens were elevated in 6 percent of glaucoma patients but in 9.2 percent of participants without glaucoma.

The allergens from cats and cockroaches may have biochemical or physical properties that trigger antibodies targeting the optic nerve, according to the study. Dogs spend more time outdoors, which may explain why dog allergens may behave differently, the researchers say. 

Related: Marijuana and optometry-practicing post legalization

IgE levels are elevated in several immunological disorders, and researchers say this study’s results raise the possibility that the immune system plays a role in glaucoma.

Next: Should your patients kick Fluffy to the curb?

 

Should your patients kick Fluffy to the curb?*

Optometry Times Editorial Advisory Board member Mohammad Rafieetary, OD, FAAO, says the study’s findings are very interesting, but agrees with the authors that the findings will need additional evaluation and scrutiny.  

“I am doubtful any clinical practice pattern changes will be made based on these findings,” says Dr. Rafieetary. “Nevertheless, when possible avoidance of environmental allergens, particularly those by pests such as cockroaches and mites will be beneficial for many health conditions, for example asthma.”

Optometry Times Editorial Advisory Board member Ben Casella, OD, FAAO, agreed that it was an interesting study.

“I must admit, I was intrigued by this paper,” he says. “A relationship of immunoglobulins to glaucoma would more likely a correlative one rather than causal.  Of note, various types of glaucomas were not differentiated in this study.”  

Related: New technology could replace eye drops

But fret not-your glaucoma treatment plan doesn’t have to include advising that your patients’ cats-or, uh, their pet cockroaches-get the boot.

“All in all, this is an interesting catalyst for more research in this area, but I don't think it's time to kick Fluffy to the curb just yet,” Dr. Casella says.

*Just kidding, of course. Optometry Times does not advocate the abandonment of your four-legged friends.

 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
© 2025 MJH Life Sciences

All rights reserved.